Advertisement

Connexin 36 Controls Synchronization of Ca2+ Oscillations and Insulin Secretion in MIN6 Cells

  1. Alessandra Calabrese1,
  2. Min Zhang2,
  3. Véronique Serre-Beinier1,
  4. David Caton1,
  5. Christophe Mas1,
  6. Leslie S. Satin2 and
  7. Paolo Meda1
  1. 1Department of Morphology, University of Geneva, Geneva, Switzerland
  2. 2Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia

    Abstract

    Cx36 is the predominant connexin isoform expressed by pancreatic β-cells. However, little is known about the role of this protein in the functioning of insulin-secreting cells. To address this question, we searched for a cell line expressing Cx36 and having glucose-induced insulin secretion comparable to that of primary β-cells. By evaluating Cx36 expression in MIN6, βTC3, RIN2A, INS1, and HIT cell lines, which differ in their sensitivity to glucose, we found that wild-type MIN6 cells fit these requirements. Therefore, we stably transfected MIN6 cells with a cDNA coding for a Cx36 antisense sequence to study the role of Cx36 in these cells. Independent clones of MIN6 cells were obtained that had a markedly reduced Cx36 expression. Loss of Cx36 decreased functional gap junctional conductance in these clones. This alteration impaired the synchronization of glucose-induced [Ca2+]i oscillations and insulin secretion in response to glucose, to secretagogues that increase [cAMP]i, and to depolarizing conditions. These data provide the first evidence that Cx36-made channels 1) mediate functional coupling in MIN6 cells, 2) provide for synchronous [Ca2+]i oscillations, and 3) are necessary for proper insulin secretion in response to metabolizable and nonmetabolizable secretagogues.

    Footnotes

    • Address correspondence and reprint requests to Alessandra Calabrese, Department of Morphology, University of Geneva, C.M.U., 1 rue Michel Servet, 1211 Geneva 4, Switzerland. E-mail: alessandra.calabrese{at}medecine.unige.ch.

      Received for publication 2 August 2002 and accepted in revised form 5 November 2002.

      [Ca2+]i, cytoplasmic-free Ca2+; FSK, forskolin; Gc, gap junctional conductance; IBMX, 3-isobutyl-1-methylxanthine; TEA, tetraethylammonium.

    | Table of Contents
    Advertisement